Animal Antibiotics and Antimicrobials Market Report 2026

Animal Antibiotics and Antimicrobials Market Overview

• Animal Antibiotics and Antimicrobials market size has reached to $5.64 billion in 2025 • Expected to grow to $8.03 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Increased Demand For Animal-Derived Products • Market Trend: Innovation In Injectable Multi-Species Antibiotics Driving Advanced Livestock Disease Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Animal Antibiotics and Antimicrobials Market?

The animal antibiotics and antimicrobials refer to veterinary medications that work against bacteria or microorganisms by either killing bacteria/microorganisms or limiting their development and multiplication. These medications are used in animals to treat clinical diseases, to prevent or control common disease events, and enhance animal growth. The main types of animal antibiotics and antimicrobials include tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. Tetracyclines are bacteriostatic, and their mechanism of action is through reversible binding of bacterial 30S ribosomes and alteration of bacterial cytoplasmic membrane. They are also referred to as oral medication used in treatment of bacterial infections due to aerobic, gram-negative bacteria, mycoplasma, and others. These are delivered in different forms including premixes, oral powder, oral solutions, injection, and others. These medications are used in both companion and food-producing animals.

What Is The Animal Antibiotics and Antimicrobials Market Growth Forecast?

The animal antibiotics and antimicrobials market size is expected to see strong growth in the next few years. It will grow to $8.03 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to stricter regulations on antimicrobial resistance, growing demand for safe animal-derived food products, increasing companion animal ownership, rising investment in veterinary drug r&d, expansion of preventive animal healthcare practices. Major trends in the forecast period include precision veterinary medicine adoption, sustainable livestock health management, digital monitoring of antimicrobial usage, ai-enabled drug discovery for veterinary antibiotics, smart manufacturing of veterinary pharmaceuticals.

Global Animal Antibiotics and Antimicrobials Market Segmentation

1) By Type Of Product: Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Type Of Products 2) By Mode Of Delivery: Premixes, Oral Powder, Oral Solution, Injection, Other Modes Of Delivery 3) By Animal Type: Food-Producing Animals, Companion Animals Subsegments: 1) By Tetracyclines: Oxytetracycline, Chlortetracycline, Doxycycline 2) By Penicillin: Penicillin G, Ampicillin, Amoxicillin 3) By Sulfonamides: Sulfadimidine, Sulfadiazine, Sulfamethoxazole 4) By Macrolides: Erythromycin, Tylosin, Tulathromycin 5) By Aminoglycosides: Gentamicin, Neomycin, Streptomycin 6) By Lincosamides: Lincomycin, Clindamycin 7) By Fluoroquinolones: Enrofloxacin, Marbofloxacin, Ciprofloxacin 8) By Cephalosporins: Cefquinome, Cephalexin, Cefoperazone 9) By Other Type Of Products: Nitrofurans, Phenicols

What Is The Driver Of The Animal Antibiotics and Antimicrobials Market?

Rising demand for animal-derived food products is driving the growth of the animal antibiotics and antimicrobials market. Animal-derived food products such as milk, eggs, meat, and others act a major source of nutrition and plays a prominent role in human diet. The companies/institutions involved in production of animal-derived foods are focusing on developing healthy herd or disease-free herd through utilization of animal antibiotics and antimicrobials on precautionary basis. For instance, in June 2023, according to a report published by the Food and Agriculture Organization (FAO), an Italy-based specialized agency of the United Nations, global meat production is projected to increase modestly by 0.8 percent in 2023, reaching 365 million tonnes (carcass weight equivalent) compared to 2022. Therefore, increasing demand for animal-derived food products is expected to boost demand for animal antibiotics and antimicrobials during forecast period.

Key Players In The Global Animal Antibiotics and Antimicrobials Market

Major companies operating in the animal antibiotics and antimicrobials market are C. H. Boehringer Sohn AG & Co. KG, Zoetis Inc., Elanco Animal Health Inc., Merck & Co. Inc., Phibro Animal Health Corp., Ashish Life Science Pvt. Limited, Ayurvet Limited, Dechra Pharmaceuticals Plc, Huvepharma Inc., Inovet (V. M. D. nv/sa), Kyoritsu Seiyaku Corporation, Lutim Pharma Private Limited, Neogen Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., UCBVET Animal Health, Vetoquinol, Virbac, Zydus Animal Health Limited, China Animal Husbandry Co. Ltd., Norbrook Laboratories Limited, Biovet AD - Peshtera, Bio Agri Mix LP, Bioiberica S. A. U., Ceva Santé Animale

Global Animal Antibiotics and Antimicrobials Market Trends and Insights

Major companies operating in the animal antibiotics and antimicrobials market are focusing on developing innovative solutions, such as novel injectable multi-species treatments, to enhance therapeutic efficacy, improve ease of administration across different livestock species, and address the growing demand for effective disease management solutions amid rising concerns over animal health, productivity, and antimicrobial resistance. A novel injectable multi-species treatment refers to a newly developed (innovative) injectable medication that is designed to be safely and effectively used across multiple animal species, such as cattle, swine, sheep, or goats, rather than being limited to a single species. For instance, in February 2025, Elanco Animal Health Incorporated, a US-based animal health company, launched Pradalex (pradofloxacin injection), an innovative antibiotic specifically indicated for the treatment of bovine respiratory disease (BRD) and swine respiratory disease (SRD), marking the first new molecule and injectable antibiotic for these indications approved by the U.S. FDA in roughly two decades. Pradalex’s novel mode of action enables comprehensive coverage against major BRD and SRD bacteria, delivers high therapeutic concentrations rapidly post-injection, and features an industry-leading withdrawal period, enhancing both efficacy and producer convenience while fitting into integrated disease management programs on farms. This launch underscores how market players are advancing antimicrobial therapies to address significant livestock health challenges, improve animal welfare, and support sustainable production systems.

What Are Latest Mergers And Acquisitions In The Animal Antibiotics and Antimicrobials Market?

In July 2024, Merck Sharp & Dohme LLC, a US-based provider of veterinary pharmaceuticals, vaccines, biologicals, and health solutions for livestock, companion animals, and aquaculture, acquired Elanco Animal Health Incorporated’s aqua business for an undisclosed amount. With this acquisition, Merck Animal Health aimed to significantly strengthen and scale its global aquaculture portfolio, expand its presence in high-growth aquatic species markets, and enhance its long-term growth strategy in fish health and sustainability solutions. Elanco Animal Health Incorporated is a US-based provider of aquaculture health products, offering vaccines, therapeutics, and nutritional solutions designed to prevent and treat diseases in farmed fish across major aquaculture regions worldwide.

Regional Outlook

North America was the largest region in the animal antibiotics and antimicrobials market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Animal Antibiotics and Antimicrobials Market?

The animal antibiotics and antimicrobials market consists of sales of glycopeptides, ß-Lactam antibiotics, and polymixins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.